دورية أكاديمية

Pediatric medulloblastoma – update on molecular classification driving targeted therapies.

التفاصيل البيبلوغرافية
العنوان: Pediatric medulloblastoma – update on molecular classification driving targeted therapies.
المؤلفون: DeSouza, Ruth-Mary, Jones, Benjamin R. T., Lowis, Stephen P., Kurian, Kathreena M.
المصدر: Frontiers in Oncology; Jul2014, Vol. 4, p1-8, 8p
مصطلحات موضوعية: MEDULLOBLASTOMA, BRAIN cancer research, CHILDHOOD cancer, TUMORS in children, CANCER treatment
مستخلص: As advances in the molecular and genetic profiling of pediatric medulloblastoma evolve, associations with prognosis and treatment are found (prognostic and predictive biomarkers) and research is directed at molecular therapies. Medulloblastoma typically affects young patients, where the implications of any treatment on the developing brain must be carefully considered. The aim of this article is to provide a clear comprehensible update on the role molecular profiling and subgroups in pediatric medulloblastoma as it is likely to contribute significantly toward prognostication. Knowledge of this classification is of particular interest because there are new molecular therapies targeting the Shh subgroup of medulloblastomas. [ABSTRACT FROM AUTHOR]
Copyright of Frontiers in Oncology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:2234943X
DOI:10.3389/fonc.2014.00176